Published in Development on February 11, 2010
The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science (2013) 4.12
Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell (2011) 4.04
Trithorax group proteins: switching genes on and keeping them active. Nat Rev Mol Cell Biol (2011) 2.56
The inactive X chromosome adopts a unique three-dimensional conformation that is dependent on Xist RNA. Genes Dev (2011) 2.53
Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation. Nat Rev Genet (2011) 2.39
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
Noncoding RNA and Polycomb recruitment. RNA (2013) 2.00
Gracefully ageing at 50, X-chromosome inactivation becomes a paradigm for RNA and chromatin control. Nat Rev Mol Cell Biol (2011) 1.66
Smchd1-dependent and -independent pathways determine developmental dynamics of CpG island methylation on the inactive X chromosome. Dev Cell (2012) 1.47
Spreading of X chromosome inactivation via a hierarchy of defined Polycomb stations. Genome Res (2012) 1.35
Xist regulation and function explored. Hum Genet (2011) 1.28
New and Xisting regulatory mechanisms of X chromosome inactivation. Curr Opin Genet Dev (2012) 1.23
Evolutionary diversity and developmental regulation of X-chromosome inactivation. Hum Genet (2011) 1.20
Nuclear matrix factor hnRNP U/SAF-A exerts a global control of alternative splicing by regulating U2 snRNP maturation. Mol Cell (2012) 1.14
Dosage compensation in mammals. Cold Spring Harb Perspect Biol (2015) 1.07
Identification of Spen as a Crucial Factor for Xist Function through Forward Genetic Screening in Haploid Embryonic Stem Cells. Cell Rep (2015) 1.07
Advances in understanding chromosome silencing by the long non-coding RNA Xist. Philos Trans R Soc Lond B Biol Sci (2013) 1.04
A scaffold for X chromosome inactivation. Hum Genet (2011) 1.01
Mechanistic insights into chromosome-wide silencing in X inactivation. Hum Genet (2011) 1.00
Long noncoding RNA PANDA and scaffold-attachment-factor SAFA control senescence entry and exit. Nat Commun (2014) 0.99
Reactivation of the inactive X chromosome in development and reprogramming. Cell Mol Life Sci (2012) 0.98
Long nonoding RNAs in the X-inactivation center. Chromosome Res (2013) 0.92
Establishment of epigenetic patterns in development. Chromosoma (2012) 0.90
The Mbd1-Atf7ip-Setdb1 pathway contributes to the maintenance of X chromosome inactivation. Epigenetics Chromatin (2014) 0.87
Role of ATRX in chromatin structure and function: implications for chromosome instability and human disease. Reproduction (2011) 0.86
A system for imaging the regulatory noncoding Xist RNA in living mouse embryonic stem cells. Mol Biol Cell (2011) 0.83
Xist Exon 7 Contributes to the Stable Localization of Xist RNA on the Inactive X-Chromosome. PLoS Genet (2015) 0.82
XIST RNA: a window into the broader role of RNA in nuclear chromosome architecture. Philos Trans R Soc Lond B Biol Sci (2017) 0.82
Evaluating GWAS-identified SNPs for age at natural menopause among chinese women. PLoS One (2013) 0.81
Progress in understanding the molecular mechanism of Xist RNA function through genetics. Philos Trans R Soc Lond B Biol Sci (2017) 0.80
Impact of flanking chromosomal sequences on localization and silencing by the human non-coding RNA XIST. Genome Biol (2015) 0.80
eXIST with matrix-associated proteins. Trends Cell Biol (2011) 0.78
The evolutionary pathway of x chromosome inactivation in mammals. Acta Naturae (2013) 0.78
Epigenetics of pluripotent cells. Acta Naturae (2012) 0.78
Active chromatin marks are retained on X chromosomes lacking gene or repeat silencing despite XIST/Xist expression in somatic cell hybrids. PLoS One (2010) 0.77
Xist RNA repeat E is essential for ASH2L recruitment to the inactive X and regulates histone modifications and escape gene expression. PLoS Genet (2017) 0.77
Regulation of Mammalian Gene Dosage by Long Noncoding RNAs. Biomolecules (2013) 0.76
The "lnc" between 3D chromatin structure and X chromosome inactivation. Semin Cell Dev Biol (2016) 0.75
Insight into lncRNA biology using hybridization capture analyses. Biochim Biophys Acta (2015) 0.75
X Inactivation Lessons from Differentiating Mouse Embryonic Stem Cells. Stem Cell Rev (2015) 0.75
Repeat E anchors Xist RNA to the inactive X chromosomal compartment through CDKN1A-interacting protein (CIZ1). Proc Natl Acad Sci U S A (2017) 0.75
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature (2007) 65.18
Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64
Genome regulation by polycomb and trithorax proteins. Cell (2007) 11.96
Role of histone H3 lysine 27 methylation in X inactivation. Science (2003) 9.85
Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell (2006) 8.53
Requirement for Xist in X chromosome inactivation. Nature (1996) 8.24
Establishment of histone h3 methylation on the inactive X chromosome requires transient recruitment of Eed-Enx1 polycomb group complexes. Dev Cell (2003) 7.11
Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis (2006) 6.64
Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol (2004) 6.55
A resource for large-scale RNA-interference-based screens in mammals. Nature (2004) 6.36
Epigenetic dynamics of imprinted X inactivation during early mouse development. Science (2003) 5.80
Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation. Dev Cell (2004) 5.72
XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear/chromosome structure. J Cell Biol (1996) 5.51
Chromosomal silencing and localization are mediated by different domains of Xist RNA. Nat Genet (2002) 5.51
Xist-deficient mice are defective in dosage compensation but not spermatogenesis. Genes Dev (1997) 4.90
Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1. Genes Dev (2003) 4.73
Chromatin remodeling in dosage compensation. Annu Rev Genet (2005) 4.62
A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation. Mol Cell (2000) 4.26
A chromosomal memory triggered by Xist regulates histone methylation in X inactivation. PLoS Biol (2004) 4.23
Dosage compensation in mammals: fine-tuning the expression of the X chromosome. Genes Dev (2006) 4.17
Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing. EMBO J (2006) 4.16
Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature (1998) 3.93
Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nat Struct Mol Biol (2006) 3.54
A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced. Genes Dev (2006) 3.41
Synergism of Xist RNA, DNA methylation, and histone hypoacetylation in maintaining X chromosome inactivation. J Cell Biol (2001) 2.94
Imprinted X inactivation maintained by a mouse Polycomb group gene. Nat Genet (2001) 2.63
Conditional deletion of Xist disrupts histone macroH2A localization but not maintenance of X inactivation. Nat Genet (1999) 2.62
SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells. Dev Cell (2009) 2.57
X-Inactivation and histone H4 acetylation in embryonic stem cells. Dev Biol (1996) 2.50
The human X-inactivation centre is not required for maintenance of X-chromosome inactivation. Nature (1994) 2.32
SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation. Nat Genet (2008) 2.19
Ring1b-mediated H2A ubiquitination associates with inactive X chromosomes and is involved in initiation of X inactivation. J Biol Chem (2004) 2.15
Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res (2002) 2.03
SAF-Box, a conserved protein domain that specifically recognizes scaffold attachment region DNA. Mol Cell Biol (2000) 1.84
Ring1B is crucial for the regulation of developmental control genes and PRC1 proteins but not X inactivation in embryonic cells. J Cell Biol (2007) 1.82
X inactivation in the mouse embryo deficient for Dnmt1: distinct effect of hypomethylation on imprinted and random X inactivation. Dev Biol (2000) 1.80
Histone macroH2A1.2 relocates to the inactive X chromosome after initiation and propagation of X-inactivation. J Cell Biol (1999) 1.64
Developmentally regulated alterations in Polycomb repressive complex 1 proteins on the inactive X chromosome. J Cell Biol (2004) 1.57
Dynamic relocalization of histone MacroH2A1 from centrosomes to inactive X chromosomes during X inactivation. J Cell Biol (2000) 1.47
Integrated kinetics of X chromosome inactivation in differentiating embryonic stem cells. Cytogenet Genome Res (2002) 1.42
De novo DNA methylation is dispensable for the initiation and propagation of X chromosome inactivation. Development (2004) 1.39
The novel SAR-binding domain of scaffold attachment factor A (SAF-A) is a target in apoptotic nuclear breakdown. EMBO J (1997) 1.37
Scaffold attachment factor A (SAF-A) is concentrated in inactive X chromosome territories through its RGG domain. Chromosoma (2003) 1.31
Weak but uniform enrichment of the histone variant macroH2A1 along the inactive X chromosome. Mol Cell Biol (2008) 1.13
The human trithorax protein hASH2 functions as an oncoprotein. Cancer Res (2008) 1.08
A stable proteinaceous structure in the territory of inactive X chromosomes. J Biol Chem (2004) 1.06
Hypomorphic mutation in hnRNP U results in post-implantation lethality. Transgenic Res (2005) 1.01
Rhythmic SAF-A binding underlies circadian transcription of the Bmal1 gene. Mol Cell Biol (2008) 0.91
Activation and repression activities of ash2 in Drosophila wing imaginal discs. Development (2004) 0.86
Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis (2006) 6.64
Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med (2011) 5.66
Ring1B compacts chromatin structure and represses gene expression independent of histone ubiquitination. Mol Cell (2010) 4.69
A chromosomal memory triggered by Xist regulates histone methylation in X inactivation. PLoS Biol (2004) 4.23
Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing. EMBO J (2006) 4.16
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Invest (2004) 3.92
LINE-1 activity in facultative heterochromatin formation during X chromosome inactivation. Cell (2010) 3.70
Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov (2003) 3.51
A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced. Genes Dev (2006) 3.41
Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest (2002) 2.85
RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3. Cell (2012) 2.77
Derivation of haploid embryonic stem cells from mouse embryos. Nature (2011) 2.66
Polycomb complexes act redundantly to repress genomic repeats and genes. Genes Dev (2010) 2.63
SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells. Dev Cell (2009) 2.57
Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res (2010) 2.37
Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium. Cell Cycle (2009) 2.28
Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol (2004) 2.19
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev (2005) 2.18
Nonoverlapping functions of the Polycomb group Cbx family of proteins in embryonic stem cells. Cell Stem Cell (2012) 2.11
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum (2004) 1.94
Wapl is an essential regulator of chromatin structure and chromosome segregation. Nature (2013) 1.92
Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J Clin Invest (2007) 1.86
Ring1B is crucial for the regulation of developmental control genes and PRC1 proteins but not X inactivation in embryonic cells. J Cell Biol (2007) 1.82
Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J Surg Res (2009) 1.76
Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation (2005) 1.75
Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum (2002) 1.72
Xist and the order of silencing. EMBO Rep (2007) 1.55
Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study. Arthritis Rheum (2004) 1.51
Hematopoietic precursor cells transiently reestablish permissiveness for X inactivation. Mol Cell Biol (2006) 1.34
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice. Arthritis Rheum (2003) 1.31
Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy. Cell Cycle (2014) 1.30
The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? Arthritis Res Ther (2008) 1.30
A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells in S/G2/M phases. Clin Cancer Res (2013) 1.29
Breathing-in epigenetic change with vitamin C. EMBO Rep (2013) 1.29
Antibiotics: a shot in the arm. Nature (2004) 1.29
Hyperplasia and carcinomas in Pten-deficient mice and reduced PTEN protein in human bladder cancer patients. Cancer Res (2006) 1.29
Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells. Arthritis Rheum (2009) 1.28
Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy. Int J Cancer (2006) 1.27
The Xist RNA A-repeat comprises a novel AUCG tetraloop fold and a platform for multimerization. RNA (2011) 1.26
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. Am J Pathol (2004) 1.24
Regulation of anaphylactic responses by phosphatidylinositol phosphate kinase type I {alpha}. J Exp Med (2005) 1.22
Activation of extracellular signal-regulated kinase by ultraviolet is mediated through Src-dependent epidermal growth factor receptor phosphorylation. Its implication in an anti-apoptotic function. J Biol Chem (2001) 1.21
Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling. Proc Natl Acad Sci U S A (2009) 1.20
Pten deficiency in melanocytes results in resistance to hair graying and susceptibility to carcinogen-induced melanomagenesis. Cancer Res (2008) 1.19
Germline potential of parthenogenetic haploid mouse embryonic stem cells. Development (2012) 1.19
Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade. Arthritis Rheum (2003) 1.17
A nonclassical vitamin D receptor pathway suppresses renal fibrosis. J Clin Invest (2013) 1.16
The A-repeat links ASF/SF2-dependent Xist RNA processing with random choice during X inactivation. Nat Struct Mol Biol (2010) 1.14
Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy. Ann Rheum Dis (2007) 1.13
Weak but uniform enrichment of the histone variant macroH2A1 along the inactive X chromosome. Mol Cell Biol (2008) 1.13
CD44 is a determinant of inflammatory bone loss. J Exp Med (2005) 1.10
Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus. Arthritis Rheum (2007) 1.10
Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation. J Bone Miner Res (2004) 1.09
Cancer cells mimic in vivo spatial-temporal cell-cycle phase distribution and chemosensitivity in 3-dimensional Gelfoam® histoculture but not 2-dimensional culture as visualized with real-time FUCCI imaging. Cell Cycle (2015) 1.09
HOXA10 is a critical regulator for hematopoietic stem cells and erythroid/megakaryocyte development. Blood (2007) 1.02
RNA chaperone activity of protein components of human Ro RNPs. RNA (2005) 1.01
Mechanistic insights into chromosome-wide silencing in X inactivation. Hum Genet (2011) 1.00
Real-time imaging of single cancer-cell dynamics of lung metastasis. J Cell Biochem (2010) 1.00
Histone acetylation controls the inactive X chromosome replication dynamics. Nat Commun (2011) 1.00
JNK1 is not essential for TNF-mediated joint disease. Arthritis Res Ther (2004) 0.99
Hepatic gene expression in hepatocyte-specific Pten deficient mice showing steatohepatitis without ethanol challenge. Hepatol Res (2006) 0.99
Does mixed connective tissue disease exist? Yes. Rheum Dis Clin North Am (2005) 0.99
Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice. Hepatology (2014) 0.99
Reactivation of the inactive X chromosome in development and reprogramming. Cell Mol Life Sci (2012) 0.98
Imaging the efficacy of UVC irradiation on superficial brain tumors and metastasis in live mice at the subcellular level. J Cell Biochem (2013) 0.97
Colonoscopic classification of internal hemorrhoids: usefulness in endoscopic band ligation. J Gastroenterol Hepatol (2005) 0.97
Lineage-specific function of the noncoding Tsix RNA for Xist repression and Xi reactivation in mice. Genes Dev (2011) 0.96
Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritis. Arthritis Res Ther (2010) 0.96
SEK1/MKK4-mediated SAPK/JNK signaling participates in embryonic hepatoblast proliferation via a pathway different from NF-kappaB-induced anti-apoptosis. Dev Biol (2002) 0.96
Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. J Autoimmun (2009) 0.96
Fluorescent proteins enhance UVC PDT of cancer cells. Anticancer Res (2012) 0.96
Phenotypic and functional deficiencies of monocyte-derived dendritic cells in systemic lupus erythematosus (SLE) patients. Int Immunol (2004) 0.95
Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis. J Immunol (2002) 0.95
Cell death and cytokine production induced by autoimmunogenic hydrocarbon oils. Autoimmunity (2012) 0.94
The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing. Epigenetics Chromatin (2013) 0.91
Combined measurement of X-ray photon correlation spectroscopy and diffracted X-ray tracking using pink beam X-rays. J Synchrotron Radiat (2013) 0.91
The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis. J Immunol (2007) 0.91
Pro-inflammatory cytokines in rheumatoid arthritis: pathogenetic and therapeutic aspects. Clin Rev Allergy Immunol (2005) 0.90
Establishment of epigenetic patterns in development. Chromosoma (2012) 0.90
Retroflexed endoscopic multiple band ligation of symptomatic internal hemorrhoids. Gastrointest Endosc (2004) 0.90
X chromosome inactivation sparked by non-coding RNAs. RNA Biol (2009) 0.90
Color-coded real-time cellular imaging of lung T-lymphocyte accumulation and focus formation in a mouse asthma model. J Allergy Clin Immunol (2010) 0.89
Anti-hnRNP and other autoantibodies in systemic sclerosis with joint involvement. Rheumatology (Oxford) (2009) 0.88
Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells. Exp Cell Res (2005) 0.88
Overexpression of tumor necrosis factor causes bilateral sacroiliitis. Arthritis Rheum (2004) 0.88
Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort. Ann Rheum Dis (2012) 0.87
Indirectly illuminated X-ray area detector for X-ray photon correlation spectroscopy. J Synchrotron Radiat (2010) 0.87
X inactivation and disease. Semin Cell Dev Biol (2009) 0.87
Synergy of Eed and Tsix in the repression of Xist gene and X-chromosome inactivation. EMBO J (2008) 0.86
Stress induces mitochondria-mediated apoptosis independent of SAPK/JNK activation in embryonic stem cells. J Biol Chem (2003) 0.85
Ultrasonographically assessed carotid atherosclerosis in Japanese type 2 diabetic patients: Role of nonesterified fatty acids. Metabolism (2002) 0.85
Mechanism of resistance to trastuzumab and molecular sensitization via ADCC activation by exogenous expression of HER2-extracellular domain in human cancer cells. Cancer Immunol Immunother (2012) 0.84
Critical role of the nucleolus in activation of the p53-dependent postmitotic checkpoint. Biochem Biophys Res Commun (2011) 0.83
The E3 ubiquitin ligase activity of Trip12 is essential for mouse embryogenesis. PLoS One (2011) 0.83
Reprogramming of Xist against the pluripotent state in fusion hybrids. J Cell Sci (2009) 0.83